Survival Outcomes in US Medicare Patients with Non-Cystic Fibrosis Bronchiectasis by Rate of Baseline Exacerbations
Abstract Introduction There are limited real-world data on outcomes in patients with non-cystic fibrosis bronchiectasis (NCFBE). This study assessed clinical characteristics and survival in patients with NCFBE by baseline exacerbation rate. Methods Patients with bronchiectasis (≥ 1 inpatient or ≥ 2...
Saved in:
| Main Authors: | Joseph Feliciano, Benjamin Lewing, Maitreyee Mohanty, Melanie Lauterio, Sebastian Fucile, Joseph Tkacz, Alan F. Barker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2024-10-01
|
| Series: | Pulmonary Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s41030-024-00275-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mortality and exacerbations in bronchiectasis patients with carbapenem-resistant Pseudomonas aeruginosa isolation: a long-term retrospective cohort study
by: Jibo Sun, et al.
Published: (2025-05-01) -
Impact of Antipseudomonal Antibiotics in Patients with Bronchiectasis Who Experienced Exacerbation or Developed Pneumonia: A Nationwide Study in Japan
by: Akihiko Hagiwara, et al.
Published: (2024-12-01) -
Changing epidemiology of non-cystic fibrosis bronchiectasis
by: Semiha Bahçeci, et al.
Published: (2016-02-01) -
The characteristics and prognosis of bronchiectasis patients with airflow limitation: a prospective longitudinal study
by: Yuanting Cai, et al.
Published: (2024-12-01) -
The Bronchiectasis Severity Index and FACED score for assessment of the severity of bronchiectasis
by: J.C. Costa, et al.
Published: (2018-05-01)